Therapeutic angiogenesis for critical limb ischaemia (Q30456666)

21 June 2017

title

Therapeutic angiogenesis for critical limb ischaemia (English)

1 reference

21 June 2017

1 reference

Brian H Annex

1 reference

21 June 2017

language of work or name

English

0 references

publication date

14 May 2013

1 reference

Nature Reviews Cardiology

21 June 2017

published in

1 reference

21 June 2017

1 reference

21 June 2017

1 reference

21 June 2017

page(s)

387-396

1 reference

Critical issues in peripheral arterial disease detection and management: a call to action

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Medical treatment of peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Medical treatment of peripheral arterial disease and claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Surgical and endovascular revision of infrainguinal vein bypass grafts: analysis of midterm outcomes from the PREVENT III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Angiogenesis: where do we stand now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Isolation of putative progenitor endothelial cells for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Skeletal muscle phenotype is associated with exercise tolerance in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Angiogenesis in skeletal muscle precede improvements in peak oxygen uptake in peripheral artery disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Lack of functional benefits following infrainguinal bypass in peripheral arterial occlusive disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Collateral density, remodeling, and VEGF-A expression differ widely between mouse strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Re-evaluating therapeutic neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

A different outlook on the role of bone marrow stem cells in vascular growth: bone marrow delivers software not hardware

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

De novo vasculogenesis in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Systems biology of pro-angiogenic therapies targeting the VEGF system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Formation of VEGF isoform-specific spatial distributions governing angiogenesis: computational analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Multiscale models of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

A compartment model of VEGF distribution in blood, healthy and diseased tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Computational kinetic model of VEGF trapping by soluble VEGF receptor-1: effects of transendothelial and lymphatic macromolecular transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermitt

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Intramuscular gene transfer of fibroblast growth factor-1 using improved pCOR plasmid design stimulates collateral formation in a rabbit ischemic hindlimb model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Local gene transfer and expression following intramuscular administration of FGF-1 plasmid DNA in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Therapeutic Angiogenesis With Intramuscular NV1FGF Improves Amputation-free Survival in Patients With Critical Limb Ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: Results of the HGF-0205 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Targeting the tumour vasculature: insights from physiological angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

The effect of gradual or acute arterial occlusion on skeletal muscle blood flow, arteriogenesis, and inflammation in rat hindlimb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Preclinical models of human peripheral arterial occlusive disease: implications for investigation of therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

A quantitative trait locus (LSq-1) on mouse chromosome 7 is linked to the absence of tissue loss after surgical hindlimb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Plasma nitrite response and arterial reactivity differentiate vascular health and performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Endothelial dysfunction--an obstacle of therapeutic angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

HIF-VEGF-VEGFR-2, TNF-alpha and IGF pathways are upregulated in critical human skeletal muscle ischemia as studied with DNA array

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Impact of mouse strain differences in innate hindlimb collateral vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

P2Y12 H2 haplotype is associated with peripheral arterial disease: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Localization of a gene for peripheral arterial occlusive disease to chromosome 1p31.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Influence of smoking on incidence and prevalence of peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Current status of cardiovascular gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

A Potential Role of Distinctively Delayed Blood Clearance of Recombinant Adeno-associated Virus Serotype 9 in Robust Cardiac Transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Adeno-associated virus serotype 9-mediated overexpression of extracellular superoxide dismutase improves recovery from surgical hind-limb ischemia in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Peripheral arterial disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Increased levels of apoptosis in gastrocnemius skeletal muscle in patients with peripheral arterial disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Arteriogenesis, the good and bad of it

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Vascular endothelial growth factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Transplacental carcinogenesis by stilbestrol

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: preliminary results of a phase I trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

IGF-I differentially regulates Bcl-xL and Bax and confers myocardial protection in the rat heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Fibrinogen genotype and risk of peripheral atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

The Basle longitudinal study: report on the relation of initial glucose level to baseline ECG abnormalities, peripheral artery disease, and subsequent mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Genetic background influences therapeutic effectiveness of VEGF

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.70

Adeno-associated virus serotype 9 efficiently targets ischemic skeletal muscle following systemic delivery.

31 March 2020

1 reference

12 December 2020

Latent adeno-associated virus infection elicits humoral but not cell-mediated immune responses in a nonhuman primate model

1 reference

12 December 2020

Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease: downregulation of HGF in response to hypoxia in vascular cells

1 reference

12 December 2020

The fate of patients with critical leg ischemia

1 reference

12 December 2020

Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC).

1 reference

12 December 2020

Surgical treatment of peripheral circulation disorders

1 reference

12 December 2020

Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion

1 reference

12 December 2020

Gene therapy from the perspective of systems biology

1 reference

12 December 2020

Relationship between leg muscle capillary density and peak hyperemic blood flow with endurance capacity in peripheral artery disease

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRCARDIO.2013.70

1 reference

21 June 2017

1 reference